Tabi Z - Search Results

1

Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes.

Salimu J, Webber J, Gurney M, Al-Taei S, Clayton A, Tabi Z. Salimu J, et al. Among authors: tabi z. J Extracell Vesicles. 2017 Sep 3;6(1):1368823. doi: 10.1080/20013078.2017.1368823. eCollection 2017. J Extracell Vesicles. 2017. PMID: 28959385 Free PMC article.

2

Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array.

Welton JL, Brennan P, Gurney M, Webber JP, Spary LK, Carton DG, Falcón-Pérez JM, Walton SP, Mason MD, Tabi Z, Clayton A. Welton JL, et al. Among authors: tabi z. J Extracell Vesicles. 2016 Jun 29;5:31209. doi: 10.3402/jev.v5.31209. eCollection 2016. J Extracell Vesicles. 2016. PMID: 27363484 Free PMC article.

3

Stroma-derived extracellular vesicle mRNA signatures inform histological nature of prostate cancer.

Shephard AP, Giles P, Mbengue M, Alraies A, Spary LK, Kynaston H, Gurney MJ, Falcón-Pérez JM, Royo F, Tabi Z, Parthimos D, Errington RJ, Clayton A, Webber JP. Shephard AP, et al. Among authors: tabi z. J Extracell Vesicles. 2021 Oct;10(12):e12150. doi: 10.1002/jev2.12150. J Extracell Vesicles. 2021. PMID: 34596356 Free PMC article.

4

Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14⁺ PD-L1⁺ phenotype in prostate cancer.

Spary LK, Salimu J, Webber JP, Clayton A, Mason MD, Tabi Z. Spary LK, et al. Among authors: tabi z. Oncoimmunology. 2014 Dec 13;3(9):e955331. doi: 10.4161/21624011.2014.955331. eCollection 2014 Oct. Oncoimmunology. 2014. PMID: 25941611 Free PMC article.

5

Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes.

Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang WG, Steadman R, Wymant J, Jones AT, Kynaston H, Mason MD, Tabi Z, Clayton A. Webber JP, et al. Among authors: tabi z. Oncogene. 2015 Jan 15;34(3):290-302. doi: 10.1038/onc.2013.560. Epub 2014 Jan 20. Oncogene. 2015. PMID: 24441045

6

Prostaglandin E₂-mediated adenosinergic effects on CD14⁺ cells: Self-amplifying immunosuppression in cancer.

Al-Taei S, Salimu J, Spary LK, Clayton A, Lester JF, Tabi Z. Al-Taei S, et al. Among authors: tabi z. Oncoimmunology. 2016 Dec 8;6(2):e1268308. doi: 10.1080/2162402X.2016.1268308. eCollection 2017. Oncoimmunology. 2016. PMID: 28344879 Free PMC article.

7

Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.

Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Clayton A, et al. Among authors: tabi z. Cancer Res. 2007 Aug 1;67(15):7458-66. doi: 10.1158/0008-5472.CAN-06-3456. Cancer Res. 2007. PMID: 17671216

8

Cancer exosomes trigger fibroblast to myofibroblast differentiation.

Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Webber J, et al. Among authors: tabi z. Cancer Res. 2010 Dec 1;70(23):9621-30. doi: 10.1158/0008-5472.CAN-10-1722. Epub 2010 Nov 23. Cancer Res. 2010. PMID: 21098712

9

Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.

Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z. Clayton A, et al. Among authors: tabi z. J Immunol. 2011 Jul 15;187(2):676-83. doi: 10.4049/jimmunol.1003884. Epub 2011 Jun 15. J Immunol. 2011. PMID: 21677139

10

Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform.

Webber J, Stone TC, Katilius E, Smith BC, Gordon B, Mason MD, Tabi Z, Brewis IA, Clayton A. Webber J, et al. Among authors: tabi z. Mol Cell Proteomics. 2014 Apr;13(4):1050-64. doi: 10.1074/mcp.M113.032136. Epub 2014 Feb 6. Mol Cell Proteomics. 2014. PMID: 24505114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters